Jeff Ajer
Director/Board Member at NEKTAR THERAPEUTICS
Net worth: 6 M $ as of 2024-03-30
Profile
Jeffrey Robert Ajer is an Independent Director at Nektar Therapeutics since 2017.
He is also the Chief Commercial Officer & Executive VP at BioMarin Pharmaceutical, Inc. since 2005.
Previously, he worked as the Director-Purchasing Worldwide at Bausch Health Americas, Inc. from 1986 to 1999.
He also held positions at SangStat Medical Corp., True North Therapeutics, Inc., and Genzyme Corp.
In terms of education, Mr. Ajer completed his undergraduate degree and MBA at the University of California, Irvine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-14 | 71,467 ( 0.04% ) | 6 M $ | 2024-03-30 | |
NEKTAR THERAPEUTICS
0.02% | 2023-09-18 | 34,153 ( 0.02% ) | 31 899 $ | 2024-03-30 |
Jeff Ajer active positions
| Companies | Position | Start |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 2005-08-31 |
| NEKTAR THERAPEUTICS | Director/Board Member | 2017-09-20 |
Former positions of Jeff Ajer
| Companies | Position | End |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2005-07-31 |
| SangStat Medical Corp. | Sales & Marketing | 2002-12-31 |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 1999-06-30 |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | - |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Director/Board Member | - |
Training of Jeff Ajer
| University of California, Irvine | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Private companies | 4 |
|---|---|
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
| SangStat Medical Corp. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Jeff Ajer
